Successful Use of Dasatinib After Liver Transplantation for Imatinib-Induced Fulminant Liver Failure in Chronic Myeloid Leukemia. [electronic resource]
Producer: 20160815Description: e97-8 p. digitalISSN:- 1527-7755
- Adult
- Antineoplastic Agents -- administration & dosage
- Dasatinib -- administration & dosage
- Female
- Fusion Proteins, bcr-abl -- antagonists & inhibitors
- Humans
- Imatinib Mesylate -- administration & dosage
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Liver Failure, Acute -- chemically induced
- Liver Transplantation
- Protein Kinase Inhibitors -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.